Bio Voyager

Biotechnology Companies News

  • Developmental Drugs Draw Scrutiny From FDA Tuesday, July 19, 2011 @ 7:29AMThe Bedford Report Provides Equity Research on BioSante & AVI BioPharma
  • Alnylam and MIT Collaborators Publish Data on Novel Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics Tuesday, July 19, 2011 @ 7:13AMCAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, together with collaborators at the Massachusetts Institute of Technology (MIT), announced today the publication of new data describing a novel approach for systemic delivery of RNAi therapeutics using synergistic combinations of novel lipid-like materials called “lipidoids ...
  • Spanish Drug Companies Have New Support Option for the U.S. Market Tuesday, July 19, 2011 @ 7:08AMBARCELONA, Spain, July 19, 2011 /PRNewswire/ -- Spanish drug companies face a number of obstacles to commercialize products or technologies in the United States. From regulatory (FDA) and GMP compliance, to distribution agreements and the search for project funding, there are many areas that must be coordinated. Those issues have just become easier to manage as Spanish company KIM and U.S ...
  • EPA to expand Cooperative Research And Development Agreement with NanoLogix Tuesday, July 19, 2011 @ 6:24AMNanoLogix, a biotechnology innovator in the rapid detection and identification of live-cell bacteria and microorganisms, announced today the U.S. Environmental Protection Agency (EPA) intends to expand its Cooperative Research And Development Agreement (CRADA) with NanoLogix to include additional water-borne pathogens.
  • Life Science award for Redd&Whyte Tuesday, July 19, 2011 @ 6:19AMRedd&Whyte, the Suffolk UK-based specialist provider of novel liquid handling technology, was awarded Best New Company at the inaugural Life Science Awards, in Hamburg, preceding the first European Lab Automation conference and exhibition. Read more...
  • Record S&P 500 Return on Equity Over Bond Yields Spurs Bulls Monday, July 18, 2011 @ 3:46AMStandard & Poor’s 500 Index companies are returning more than ever in earnings compared with their borrowing costs, a signal that takeovers and capital spending will help investors overcome a slowing U.S. economy.
  • Take care investing in biotech companies Monday, July 18, 2011 @ 2:33AMIt's easy to drool over biotechnology companies that are busy developing tomorrow's blockbuster medications. Some will end up delivering powerful long-term performances. It's hard to know which ones, though, ...
  • Boston firms search for next Zuckerberg Monday, July 18, 2011 @ 2:30AMMark Zuckerberg was the big one that got away. Boston venture capitalists declined to fund the founder of Facebook, the world's most popular social networking service, when he sought money to expand his startup in 2004.
  • Greenpeace asks DOJ to junk malicious mischief case over Bt talong Monday, July 18, 2011 @ 2:20AMGreenpeace has asked the Department of Justice to dismiss the malicious mischief case that a group of promoters of genetically modified organisms filed against the environmental group.
  • Angel Biotechnology - Half Yearly Report Monday, July 18, 2011 @ 1:49AMAngel Biotechnology - Half Yearly Report
  • U.Va. research helps push ideas to market Monday, July 18, 2011 @ 1:48AMCHARLOTTESVILLE — For officials at the University of Virginia, spinning off biotechnology companies isn't an explicit goal. Rather, it's one of several techniques used to push breakthroughs from the academic world to the practical.
  • Cephalon Shareholders Approve Acquisition by Teva Thursday, July 14, 2011 @ 1:08PMFRAZER, Pa., July 14, 2011 /PRNewswire/ -- Cephalon, Inc. (Nasdaq: CEPH) today announced that its stockholders voted to approve the Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) proposal to acquire Cephalon for $81.50 per share in cash, or a total enterprise value of approximately $6.8 billion. The transaction remains under review by the U.S. Federal Trade Commission and the European ...
  • Iskandar always gets the job done Thursday, July 14, 2011 @ 12:45PMKUALA LUMPUR: Datuk Iskandar Mizal Mahmood burned the midnight oil writing an essay entitled "How to Rob a Bank" when he was 18.
  • Helena Guergis contravened conflict of interest act: Commish Thursday, July 14, 2011 @ 11:47AMFormer MP Helena Guergis broke Parliament's conflict of interest code by using her position to try to benefit her husband's business interests, the federal ethics watchdog says.[...]
  • ICON plc UK Regulatory Announcement: Acquisition Thursday, July 14, 2011 @ 11:41AMDUBLIN--(BUSINESS WIRE)--ICON Acquires Firecrest Clinical Acquisition Enables ICON to Enhance Investigator Site Performance & Quality Dublin, Ireland, July 14th, 2011 – ICON plc, (NASDAQ: ICLR; ISIN: IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the acquisition of Firecrest Clinical, a ...
  • Bio-Rad to Report Second-Quarter 2011 Financial Results Tuesday, August 2, 2011 Tuesday, July 12, 2011 @ 7:06PMHERCULES, CA--(Marketwire - Jul 12, 2011) - Bio-Rad Laboratories, Inc. ( NYSE : BIO ) and ( NYSE : BIO.B ), a multinational manufacturer and distributor of life science research and clinical diagnostic products, will report financial results for the second quarter 2011 on Tuesday, August 2, 2011, after the close of the market. The company will discuss these results in a conference call scheduled ...
  • KVCC Pharma Screening Center In Two Deals Tuesday, July 12, 2011 @ 2:36PMThe Michigan High Throughput Screening Center at Kalamazoo Valley Community College has been chosen to screen compounds for Alzheimer's treatment research, officials announced Tuesday. The center also announced a partnership with Genemarkers, a custom genomics research provider.
  • Mentor Capital Cancer Immunotherapy Index Outpaces Biotechs on Second Anniversary Tuesday, July 12, 2011 @ 12:58PMSAN DIEGO--(BUSINESS WIRE)--The Mentor Capital Cancer Immunotherapy Index continues to outpace the biotech sector on its second anniversary. Dendreon, Immunocellular Therapeutics and Oncothyreon are leading gainers.
  • Midday Glance: Biotechnology companies Tuesday, July 12, 2011 @ 12:18PMShares of some top biotechnology companies are mixed at 1 p.m.:
  • QIAGEN Reaches Agreement To Buy 61% Stake In Ipsogen, Plans To Fully Acquire Leader In Oncology Molecular Diagnostics Friday, July 8, 2011 @ 5:10PMVENLO, the Netherlands, July 8, 2011 /PRNewswire/ -- - Binding agreement based on terms of QIAGEN's offer in June 2011 to acquire initial stake in Ipsogen S.A. and then make tender offer for full acquisition - Ipsogen has a competitive portfolio in hematologic (blood) cancer testing with assays covering 15 biomarkers for patient profiling and monitoring - Many of Ipsogen's assays have ...
  • Final Glance: Biotechnology companies Friday, July 8, 2011 @ 5:10PMShares of some top biotechnology companies were mixed at the close of trading:
  • SurgiQuest, Inc. Secures $19 Million to Fund Commercialization and Launch the Next Generation Access Technology Cited ... Friday, July 8, 2011 @ 5:09PMORANGE, Conn., July 8, 2011 /PRNewswire/ -- SurgiQuest, Inc. ("SurgiQuest", the "Company") today announced that the Company has closed a $19 million round of financing from both current and new investors. River Cities Capital Funds of Cincinnati, Ohio led the round followed by Fletcher Spaght Ventures of Boston, Massachusetts. Additional investments from CMEA Ventures, California Technology ...
  • Medical Breakthrough: Successful Stem Cell Transplant in Sweden Friday, July 8, 2011 @ 4:30PMFinding organ donors could soon be a thing of the past. The latest miracle of modern medicine allowed doctors to replace a man’s cancerous windpipe with a new man-made one, comprised of a synthetic structure that was coated in the patient’s own stem cells.
  • ´Visiongain Celebrates its Thirteenth Anniversary This Month With Free Report Licence Upgrade Offer´ Says Commercial ... Monday, July 4, 2011 @ 5:10AMLONDON, July 4, 2011 /PRNewswire/ Visiongain started life at the height of the tech boom in the late nineties, writing newsletters and reports focusing on the booming wireless phone industry. Since those early days the company has now expanded …
  • Stem Cell Technologies: World Market Outlook 2011-2021 Monday, July 4, 2011 @ 4:26AMReportlinker.com announces that a new market research report is available in its catalogue:
  • Home-grown jugaad set for patent cover Sunday, July 3, 2011 @ 11:41PMThe idea was to give intellectual property rights to the small scale industry's innovations that lead to inventions which do not strictly conform with patent laws.
  • Three foreign companies keen on investing in Bio-City Sunday, July 3, 2011 @ 10:08PMWASHINGTON: Three foreign biotechnology-based pharmaceutical companies are interested to invest in the biotechnology hub Bio-City in Alor Gajah, Malacca.
  • non-GMO Corn Farmers Discover More Yield, Profits and Promote Sustainability with New Seed Brand from Spectrum Seed ... Tuesday, June 28, 2011 @ 11:02AMDARLINGTON, Ind.--(BUSINESS WIRE)--The newest genetic choices available enable farmers to immediately benefit from genetic yield gains without waiting for GMO trait conversions.
  • Wound Care Market Reached $15 Billion in 2010 Tuesday, June 28, 2011 @ 10:48AMROCKVILLE, MD--(Marketwire - Jun 28, 2011) - MarketResearch.com has announced the addition of the new report "World Wound Care Markets 2011," to their collection of Wound Care market reports. For more information, visit http://www.marketresearch.com/product/display.asp?ProductID=6422062
  • Wolf Greenfield Congratulates WPI Venture Forum's Five-Minute Pitch Contest Winners Tuesday, June 28, 2011 @ 10:42AMWORCESTER, MA--(Marketwire - 06/28/11) - Wolf, Greenfield & Sacks, P.C., congratulates WPI Venture Forum's Five-Minute Pitch Contest winner Factor Biosciences and runners-up Arctic Sand and Axena Technologies. All three were mentored by technology experts at Wolf Greenfield, a Boston intellectual property law firm and co-sponsor of the contest. Winners were selected separately by a panel of ...
  • DGAP-News: Apricus Biosciences' Marketing Application for Vitaros(R), for the Treatment of Erectile Dysfunction, is ... Tuesday, June 28, 2011 @ 10:36AMbrApricus Biosciences, Inc. 28.06.2011 16:47 SAN DIEGO, 2011-06-28 16:47 CEST (GLOBE NEWSWIRE) --brApricus Biosciences, Inc. ('Apricus Bio') (Nasdaq:APRI) announced today that its marketing application for Vitaros(r), indicated for the treatment of pat
  • Malaysia wants to produce own poultry vaccines Tuesday, June 28, 2011 @ 10:22AMTHE government, with the help of the world's only university vaccine centre, Maryland University, is looking into ways to produce its own poultry vaccines to fight highly- pathogenic animal diseases such as avian flu and New Castle disease.
  • Apricus Biosciences' Marketing Application for Vitaros(R), for the Treatment of Erectile Dysfunction, is Accepted for ... Tuesday, June 28, 2011 @ 10:16AMApricus Biosciences, Inc. 28.06.2011 16:47 --------------------------------------------------------------------------- SAN DIEGO, 2011-06-28 16:47 CEST (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio') (Nasdaq:APRI) announced today that its marketing application for Vitaros(r), indicated for the treatment of patients with erectile dysfunction ('ED'), has been accepted for review ...
  • Research and Markets: Understanding the Biotechnology Market - The Market Expected to Surpass Information Technology ... Tuesday, June 28, 2011 @ 10:16AMDUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/5c785f/understanding_the) has announced the addition of the "Understanding the Biotechnology Market" report to their offering. Understanding the Global Biotech Market The 21st century is witnessing the dawn of biotechnology, which is expected to surpass Information Technology as ...
  • Psynova boosted by $80m acquisition Sunday, June 26, 2011 @ 4:48AMNasdaq quoted Myriad Genetics Inc has completed the $80m (£50m) cash acquisition of Rules-Based Medicine (RBM) of which Cambridge University spin-out Psynova Neurotech Ltd is a majority-owned subsidiary. Read more...
  • Muhyiddin to Officiate International Bio Exhibition in Washington Sunday, June 26, 2011 @ 4:29AMWASHINGTON, 26 JUNE, 2011: Deputy Prime Minister Tan Sri Muhyiddin Yassin has been given the honour to officiate the 2011 BIO International Convention exhibition, the world's largest biotechnology gathering to be held here next week.
  • Clinovo Introduces New Clinical Staffing Web Platform & Talent Sunday, June 26, 2011 @ 3:10AMReinforces Clinovo’s stand as strategic partner for life sciences companies looking for a full-service CRO. Sunnyvale, CA (PRWEB) June 25, 2011 Today, Clinovo ramps up its clinical staffing activity with the introduction of a new web platform and increased personnel dedicated to its clinical staffing services. Following the growing demand for its clinical staffing services, the company doubles ...
  • UVa research helps push ideas to market Saturday, June 25, 2011 @ 10:09PMFor officials at the University of Virginia, spinning off biotechnology companies isn’t an explicit goal. Rather, it’s one of several techniques used to push breakthroughs from the academic world to the practical.
  • 12 Nations/EU Join UN Protocol on Sharing Genetic Resources Thursday, June 23, 2011 @ 9:26PMNew York, Jun 23 2011 - Twelve nations and the European Union today added their signatures to a United Nations treaty on the equitable sharing of the planet’s genetic resources in a ceremony at UN Headquarters.
  • Moodlerooms Raises $3M - cbl Thursday, June 23, 2011 @ 8:00PMBy Brian Wolak BALTIMORE -- Moodlerooms Inc. has raised $2.99 million from a $3.39 million offering,...
  • Needed: A biotech regulator Thursday, June 23, 2011 @ 6:52PMResearch in the domestic agri-biotech industry seems to be strangled by multiple ministries and state governments, with both public and private sector companies grappling to tackle contrasting regulations.
  • Oramed Pharmaceuticals Appoints Dr. Michael Berelowitz as Chairman of Scientific Advisory Board Wednesday, June 22, 2011 @ 8:20AM-
  • ´World Pre-filled Syringe Technology Revenues Will Reach $3.9bn in 2015´ Says Visiongain Report Wednesday, June 22, 2011 @ 8:09AMLONDON, June 22, 2011 /PRNewswire/ http://www.visiongain.com/Report/631/Pre-Filled-Syringes-World-Market-Outlook-2011-2021 A new report by London-based business information company visiongain, predicts that world pre-filled syringe technology …
  • MMRGlobal Joint Venture Partner Unis-Tonghe Wins Bid in China Wednesday, June 22, 2011 @ 8:03AMLOS ANGELES, CA--(Marketwire - Jun 22, 2011) - MMRGlobal, Inc. ( OTCBB : MMRF ) ("MMR") today announced Unis-Tonghe Technology (Zhengzhou) has received official notice that they are a winner of a bid to provide eHealth and Electronic Medical Record Services of 164 County/District of Henan Province in China. The Government of Henan Bidding and Procurement Service Co. Ltd released a short list of ...
  • biOasis to Present on Drug Delivery at International Conference on Cerebral Vascular Biology Wednesday, June 22, 2011 @ 8:00AMVANCOUVER, British Columbia -- biOasis Technologies Inc. is pleased to announce that it will be presenting data on its Transcend technology for delivery of drugs into the brain at the 9th annual International Conference on Cerebral Vascular Biology being held in Leiden Netherlands from June 21-25th 2011.
  • Obesity Drug Makers Fine Tune Potential Blockbusters Wednesday, June 22, 2011 @ 7:59AMThe Bedford Report Provides Equity Research on Arena Pharmaceuticals and Vivus
  • Marina Biotech and Sequenom Find Themselves in Enviable Positions Wednesday, June 22, 2011 @ 7:59AMThe Bedford Report Provides Stock Research on Marina Biotech and Sequenom
  • Neste Oil to take part in international algae research projects in Australia and the Netherlands Wednesday, June 22, 2011 @ 7:58AMESPOO, FINLAND--(Marketwire - Jun 22, 2011) -
  • Genencor Launches A Market-Leading Enzyme Product To Advance Cellulosic Biofuel Production Worldwide Wednesday, June 22, 2011 @ 7:35AMGenencor today announced a product advancement, Accellerase® TRIO. This new product will enable biofuel producers to more cost-effectively manufacture cellulosic ethanol from a wide range of renewable nonfood feedstocks such as switchgrass, wheat straw and corn stover as well as from municipal solid waste.
  • TSX may open lower as commodities weaken, Fed eyed Wednesday, June 22, 2011 @ 7:31AM(Reuters) - Toronto's main stock index looked set to open lower on Wednesday as commodity prices dropped and concerns lingered about the outlook for the U.S. economy ahead of the conclusion of a U.S. Federal Reserve meeting.